FIELD: medicine, ophthalmology, peptides. SUBSTANCE: invention relates to the use dipeptide L-Lys-L-Glu as the preparation eliciting ability inhibiting angiogenesis in ophthalmopathology. Invention proposes the pharmacological agent that is able to inhibit angiogenesis in ophthalmopathology and containing pharmaceutically acceptable carrier and dipeptide as an active component taken in effective amount. Dipeptide is the compound of the formula L-lysyl-L-glutamic acid (L-Lys-L-Glu) or its chemical modification as salts. Method of treatment in diseases and pathological states of visual organ involves curative administration to patient the effective amount of the pharmacological agent for period that is necessary to attain the therapeutic effect depending on the course of pathological process. EFFECT: stabilization of pathological process, improved visual functions. 6 cl, 3 tbl, 1 dwg
